Contribution of PARP to endothelial dysfunction and hypertension in a rat model of pre-eclampsia.

British Journal of Pharmacology
S K WalshLouise C Kenny

Abstract

Under conditions of increased oxidative stress, such as pre-eclampsia and diabetes, overstimulation of PARP leads to endothelial dysfunction. Inhibition of PARP has been demonstrated to reverse the vascular dysfunction associated with diabetes in vivo. The present study was carried out to investigate the role of PARP in mediating the endothelial dysfunction associated with pre-eclampsia. Uteroplacental perfusion was surgically reduced in pregnant rats to produce the reduced uterine perfusion pressure (RUPP) rat model of pre-eclampsia and the PARP inhibitor, PJ34, was administered either before or after surgery. Mean arterial BP and vascular function were measured in normal pregnant (NP) and both control and PJ34-treated RUPP rats. Mesenteric vessels from NP rats were incubated with either 3% RUPP or NP plasma alone or in combination with PJ34. Finally, immunohistochemical staining was carried out to measure nitrotyrosine (byproduct of peroxynitrite) immunoreactivity. RUPP rats were characterized by hypertension, fetal growth restriction and endothelial dysfunction when compared with NP rats. PJ34 administered in vivo before, but not after, surgery prevented the development of both endothelial dysfunction and hypertension. RUPP ...Continue Reading

References

Nov 1, 1996·The American Journal of Physiology·J S Beckman, W H Koppenol
Mar 5, 1999·Journal of the Society for Gynecologic Investigation·R HaymanP Baker
Feb 15, 2001·Cardiovascular and Interventional Radiology·K G CallumM Ruttley
Jun 19, 2002·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Raouf A Khalil, Joey P Granger
Sep 12, 2002·Pharmacological Reviews·László Virág, Csaba Szabó
Dec 26, 2002·American Journal of Obstetrics and Gynecology·Eimantas SvedasKarolina R Kublickiene
Dec 9, 2003·Cardiovascular Research·Christy Lynn M Cooke, Sandra T Davidge
Mar 22, 2005·British Journal of Pharmacology·Ian P CrockerPhilip N Baker
May 29, 2007·American Journal of Hypertension·Jeffrey GilbertJoey Granger
Dec 7, 2007·American Journal of Physiology. Heart and Circulatory Physiology·Jeffrey S GilbertJoey P Granger
Jan 15, 2008·Reproductive Toxicology·Natasa Z DordevićZorica S Saicić
Apr 1, 2008·Molecular and Cellular Biochemistry·Gurjit KaurRajendra Prasad
Jun 7, 2008·The American Journal of Pathology·Pal Pacher, Csaba Szabo
Jun 10, 2008·European Journal of Pharmacology·Nergiz Hacer TurgutBaris Karadas
Aug 2, 2008·American Journal of Hypertension·Mona SedeekJoey P Granger
Feb 13, 2009·British Journal of Pharmacology·Csaba Szabo
May 2, 2009·Applied Immunohistochemistry & Molecular Morphology : AIMM·Chao-Jie WangXiao-Feng Sun
Jul 8, 2010·The Journal of Gene Medicine·Carol KilkennyUNKNOWN NC3Rs Reporting Guidelines Working Group
Jul 17, 2010·The Journal of Physiology·UNKNOWN NC3Rs Reporting Guidelines Working Group
Jul 24, 2010·British Journal of Pharmacology·J C McGrathC L Wainwright
Jul 24, 2010·British Journal of Pharmacology·Carol KilkennyUNKNOWN NC3Rs Reporting Guidelines Working Group
Nov 9, 2011·British Journal of Pharmacology·Stephen P H AlexanderJohn A Peters

❮ Previous
Next ❯

Citations

Apr 24, 2012·American Journal of Physiology. Heart and Circulatory Physiology·Jing LiJane F Reckelhoff
Feb 21, 2014·Drugs·Catherine M Brown, Vesna D Garovic
Aug 20, 2014·Current Hypertension Reports·Ecaterina BerzanCatherine M Brown
Jul 31, 2013·Microcirculation : the Official Journal of the Microcirculatory Society, Inc·Lesley J BrennanSandra T Davidge

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.